SCHEMBL4390691

SCHEMBL4390691

Cc1cc(-n2c(C)cc(OC(F)c3ccccc3F)cc2=O)ccc1C(=O)O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 7/20 0.40
MYC P01106 3/20 0.37
CTSB P07858 2/20 0.37
KLKB1 P03952 1/20 0.37
ELANE P08246 1/20 0.37
MMP9 P14780 1/20 0.37
DUSP3 P51452 1/20 0.37
NR4A1 P22736 1/20 0.36
HIF1A Q16665 1/20 0.35
ALDH1A1 P00352 2/20 0.35
PKM P14618 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
POLB P06746 2/20 0.34
MEN1 O00255 1/20 0.34
MAPT P10636 1/20 0.34
MAPK1 P28482 1/20 0.34
KMT2A Q03164 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
IGLV6-57 P01721 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4386844 0.82 MAPK14 (0.41) NOTUMHIF1A
SCHEMBL4390694 0.77 NOTUM (0.44) NOTUMMYCCTSBKLKB1ELANE
SCHEMBL4390686 0.76 MRGPRX4 (0.48) NOTUMMYCCTSBKLKB1ELANE
SCHEMBL4384808 0.71 MAPK14 (0.47) ALDH1A1PKMTDP1POLBMEN1
SCHEMBL17177038 0.67 MYC (0.74) NOTUMMYCCTSBKLKB1ELANE
SCHEMBL5309567 0.66 KDM4E (0.46) ALDH1A1TDP1MEN1MAPTKMT2A
SCHEMBL19692164 0.63 NOTUM (0.42) NOTUMMYCNR4A1ALDH1A1TDP1
SCHEMBL1259810 0.62 MYC (0.57) NOTUMMYCCTSBKLKB1ELANE
SCHEMBL3301071 0.61 ALDH1A1 (0.51) ALDH1A1PKMTDP1MEN1MAPT
SCHEMBL19193471 0.59 ALDH1A1 (0.45) ALDH1A1MEN1KMT2AIGLV6-57

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7629363-B2 antiinflammatory agent for treating asthma and chronic pulmonary inflammatory disease PFIZER INC (US) 2009-12-08 US disclosed
EP-1490064-B1 SUBSTITUTED PYRIDINONES AS MODULATORS OF P38 MAP KINASE PHARMACIA CORP (US) 2009-11-18 EP disclosed
US-7067540-B2 Substituted pyridinones PHARMACIA CORPORATION (US) 2006-06-27 US disclosed
US-20050176775-A1 Substituted pyridinones PHARMACIA CORPORATION 2005-08-11 US disclosed
US-20040058964-A1 Substituted pyridinones PHARMACIA LLC 2004-03-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040058964-A1 Substituted pyridinones MAPK1, MAPK6, MAPK7 NOTUM 3993/4885MYC 4291/4885CTSB 2767/4885
US-20050176775-A1 Substituted pyridinones MAPK1, MAPK6, MAP3K6 NOTUM 4121/4885MYC 4410/4885CTSB 2580/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.